SCHEMBL30714232

SCHEMBL30714232

c1cc2cncc-2cs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13035338 0.85 CYP2A6 (1.00)
SCHEMBL30359399 0.80 CYP2A6 (1.00)
SCHEMBL3615252 0.77 CYP2A6 (1.00)
SCHEMBL30963844 0.77 CYP2A6 (0.74)
SCHEMBL2958071 0.77 CYP2A6 (1.00)
Methane SCHEMBL7424052 0.75 CYP2A6 (0.71)
SCHEMBL1356085 0.74 CYP17A1 (0.70)
SCHEMBL28176747 0.73 CYP2A6 (0.59)
SCHEMBL7424044 0.72 CYP2A6 (0.67)
SCHEMBL13035333 0.72 CYP2A6 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4540230-A1 ANILINO-PYRAZOLE DERIVATIVES, COMPOSITIONS AND METHODS THEREOF Ensem Therapeutics, Inc. (US) 2025-04-23 EP disclosed
WO-2023244710-A1 ANILINO-PYRAZOLE DERIVATIVES, COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2023-12-21 WO disclosed